Clearbridge BioLoc, announced today, the successful enhancement of their Lab-on-card Test-card to facilitate
“wet-lab” ELISA assays to be completed in almost any setting and location in under 30 minutes.
Download the Media Release (PDF): Clearbridge BioLoc derives “wet-lab” ELISA+ capability on their Lab-on-card Test-card
Clearbridge BioLoc was awarded with SPRING Singapore's Technology Enterprise
Commercialisation Scheme (TECS) Proof-of-Value (POV) Grant today.
The TECS is a competitive grant awarded to start-ups posessing strong technology Intellectual Property in addition to a scalable business model. Proposals for the grant are ranked based on the evaluation of both technical and commercial merits by a team of reviewers, and the best are funded.
SPRING Singapore is an agency under the Ministry of Trade and Industry. For information on SPRING and TECS, please visit www.spring.gov.sg.
Clearbridge BioLoc was named the Most Disruptive Innovation at
Asiasons Innovation Awards 2011 held in Marina Bay Sands Expo and Convention
Mr Johnson Chen, Director of Clearbridge BioLoc, was also presented with the Rising Star Innovator award at the event.
announced today that it has received an
investment from Tim Draper,a well-established venture capitalist
based in the Silicon Valley.
Mr Draper, who is the Founder and a Managing Director of Fisher Jurvetson (DFJ) , is well known for making early-stage investments in dynamic companies in new markets.
Clearbridge BioLoc is an incubatee under Clearbridge Accelerator.
Download the Press Release (PDF): Singapore technology incubator receives investment from Silicon Valley "Super-Angel"
For more information, please contact us at: firstname.lastname@example.org.
Clearbridge BioLoc today unveils the prototype of its flagship product, AssayQuest™
at the American Association for Clinical Chemistry (AACC) Annual Meeting 2011, in
The AssayQuest™ system is based upon a patent pending technology and has been developed in Singapore. Clearbridge BioLoc is an incubatee company of Clearbridge Accelerator , a Singapore National Research Foundation (NRF) backed medical technology incubator.
Download the Press Release (PDF): Clearbridge BioLoc unveils innovative Lab-on-Card analysis platform for Point-of-Care testing at world’s largest clinical lab conference.
For more information, please contact us at: email@example.com, firstname.lastname@example.org.
Clearbridge BioLoc will be exhibiting at the 2011 AACC Annual Meeting and Clinical Lab Expo,
held at the Georgia World Congress Center in Atlanta, Georgia (USA) from
24 - 28th July 2011. We welcome you to visit us at Booth 217, where our
representatives will be present to introduce our product and explain our
We're pleased to announce that we'll be speaking at AACC's 2011 OEM Lecture Series on 26 July 2011 (Tuesday). Our talk, "An Innovative, Ultra Low-Cost & Portable Point-of-Care Blister/Roller Pump Assay Device" will be held at 9.20am in Georgia World Congress Center Room B404. We look forward to seeing you there!
If you have any questions or would like to arrange for a meeting at AACC 2011, please email us: email@example.com
The World Economic Forum is the world’s foremost multistakeholder community bringing together leaders from business, government, media, academia and civil society. The World Economic Forum gathers innovative start-ups from around the world in the areas of IT and new media, energy and environment, and life sciences and health and recognizes Technology Pioneers for being at the forefront of innovation and entrepreneurship. The Technology Pioneers are selected by an independent committee comprised of Forum Partner companies, representatives from the venture investments community and academic leaders.
Clearbridge BioLoc was selected to be one of the best 20 Start Up companies to be showcased at TechVenture 2010. Presented by National Research Foundation (NRF) and Singapore Venture Capital and Private Equity Association (SVCA), TechVenture 2010 is Asia’s premier event for investors who represent billions of dollars of investment funds ready for deployment into Asia.
Clearbridge BioLoc was awarded SPRING's Technology Enterprise Commercialisation Scheme Proof of Concept (TECS POC) grant for its cost effective immunoassay system and platform.